Painful Muscloskeletal tumor (osteoid osteoma, metastatic MSK tumor)
Conditions
Interventions
Sponsors
Gunma University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Pathological and clinical diagnosis for Musculoskeletal tumor 2) Target lesion was detected by MRI or CT 3) Pain was difficult to be controlled by conservative treatment 4) Pain due to the lesion of at least 5 on a Numerical rating scale (NRS) 5) Adequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions 6) Performance status (ECOG): 0-2 7) Survival time was expected at least 4 weeks 8) Written informed consent from the patient or the delegate
Exclusion criteria
Exclusion criteria: 1) Association between tumor and pain is unclear 2) There was a major neurovascular structure in and around the needle access or the planned ablation area 3) Tumor could not be detected by MRI or CT 4) Bleeding tendency and coagulation disorder were observed clinically. 5) Difficult to stop anti-coagulant drug 6) Active infection and inflammatory disease 7) Over 38 degree fever 8) Patients were confirmed or suspected to be pregnant 9) Attending physician judged the patient was not appropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety (Within 1 month after the treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency and degree of the adverse event, Short-term efficacy | — |
Countries
Japan
Contacts
Public ContactMasaya Miyazaki
Gunma University Hospital Diagnostic and Interventional Radiology
Outcome results
None listed